Efficient tumour formation by single human melanoma cells
- PMID: 19052619
- PMCID: PMC2597380
- DOI: 10.1038/nature07567
Efficient tumour formation by single human melanoma cells
Abstract
A fundamental question in cancer biology is whether cells with tumorigenic potential are common or rare within human cancers. Studies on diverse cancers, including melanoma, have indicated that only rare human cancer cells (0.1-0.0001%) form tumours when transplanted into non-obese diabetic/severe combined immunodeficiency (NOD/SCID) mice. However, the extent to which NOD/SCID mice underestimate the frequency of tumorigenic human cancer cells has been uncertain. Here we show that modified xenotransplantation assay conditions, including the use of more highly immunocompromised NOD/SCID interleukin-2 receptor gamma chain null (Il2rg(-/-)) mice, can increase the detection of tumorigenic melanoma cells by several orders of magnitude. In limiting dilution assays, approximately 25% of unselected melanoma cells from 12 different patients, including cells from primary and metastatic melanomas obtained directly from patients, formed tumours under these more permissive conditions. In single-cell transplants, an average of 27% of unselected melanoma cells from four different patients formed tumours. Modifications to xenotransplantation assays can therefore dramatically increase the detectable frequency of tumorigenic cells, demonstrating that they are common in some human cancers.
Figures
Comment in
-
Cancer stem cells: Here, there, everywhere?Nature. 2008 Dec 4;456(7222):581-2. doi: 10.1038/456581a. Nature. 2008. PMID: 19052611 No abstract available.
-
Cancer stem cells are everywhere.Nat Med. 2009 Jan;15(1):23. doi: 10.1038/nm0109-23. Nat Med. 2009. PMID: 19129778 No abstract available.
Similar articles
-
Immunodeficient mouse strains display marked variability in growth of human melanoma lung metastases.Clin Cancer Res. 2009 May 15;15(10):3277-86. doi: 10.1158/1078-0432.CCR-08-2502. Epub 2009 May 15. Clin Cancer Res. 2009. PMID: 19447870 Free PMC article.
-
Identification of cells initiating human melanomas.Nature. 2008 Jan 17;451(7176):345-9. doi: 10.1038/nature06489. Nature. 2008. PMID: 18202660 Free PMC article.
-
Human CD271-positive melanoma stem cells associated with metastasis establish tumor heterogeneity and long-term growth.Cancer Res. 2011 Apr 15;71(8):3098-109. doi: 10.1158/0008-5472.CAN-10-3997. Epub 2011 Mar 10. Cancer Res. 2011. PMID: 21393506
-
Humanized NOD-SCID IL2rg–/– mice as a preclinical model for cancer research and its potential use for individualized cancer therapies.Cancer Lett. 2014 Mar 1;344(1):13-19. doi: 10.1016/j.canlet.2013.10.015. Cancer Lett. 2014. PMID: 24513265 Review.
-
Number crunching in the cancer stem cell market.Breast Cancer Res. 2009;11(2):302. doi: 10.1186/bcr2243. Epub 2009 Apr 24. Breast Cancer Res. 2009. PMID: 19439026 Free PMC article. Review.
Cited by
-
Targeting Androgen, Thyroid Hormone, and Vitamin A and D Receptors to Treat Prostate Cancer.Int J Mol Sci. 2024 Aug 26;25(17):9245. doi: 10.3390/ijms25179245. Int J Mol Sci. 2024. PMID: 39273194 Free PMC article. Review.
-
Unveiling the Dynamic Interplay between Cancer Stem Cells and the Tumor Microenvironment in Melanoma: Implications for Novel Therapeutic Strategies.Cancers (Basel). 2024 Aug 16;16(16):2861. doi: 10.3390/cancers16162861. Cancers (Basel). 2024. PMID: 39199632 Free PMC article. Review.
-
Integrin-linked kinase-frizzled 7 interaction maintains cancer stem cells to drive platinum resistance in ovarian cancer.J Exp Clin Cancer Res. 2024 Jun 1;43(1):156. doi: 10.1186/s13046-024-03083-y. J Exp Clin Cancer Res. 2024. PMID: 38822429 Free PMC article.
-
The intricate interplay between cancer stem cells and cell-of-origin of cancer: implications for therapeutic strategies.Front Oncol. 2024 May 10;14:1404628. doi: 10.3389/fonc.2024.1404628. eCollection 2024. Front Oncol. 2024. PMID: 38800385 Free PMC article. Review.
-
Recycled melanoma-secreted melanosomes regulate tumor-associated macrophage diversification.EMBO J. 2024 Sep;43(17):3553-3586. doi: 10.1038/s44318-024-00103-7. Epub 2024 May 8. EMBO J. 2024. PMID: 38719996 Free PMC article.
References
-
- Li C, Heidt DG, Dalerba P, et al. Identification of pancreatic cancer stem cells. Cancer research. 2007;67:1030–1037. - PubMed
-
- Wu C, Wei Q, Utomo V, et al. Side population cells isolated from mesenchymal neoplasms have tumor initiating potential. Cancer research. 2007;67:8216–8222. - PubMed
-
- Wang JC, Lapidot T, Cashman JD, et al. High level engraftment of NOD/SCID mice by primitive normal and leukemic hematopoietic cells from patients with chronic myeloid leukemia in chronic phase. Blood. 1998;91:2406–2414. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases